Clinical Outcome of Lipiflow Treatment Prior to Cataract Surgery in Dry Eye Patients

Not Applicable

• Conditions: Dry Eye

• Registration Number: NCT04457999
• Lead Sponsor: Samsung Medical Center

Brief Summary

To investigate the clinical outcome of Lipiflow treatment prior to cataract surgery in patients with meibomian gland dysfunction and dry eye disease

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-20
• Status Verified: 2020-07
• Study First Submitted: 2020-07-01
• Study First Submitted QC: 2020-07-01
• Last Update Submitted: 2020-07-01
• Primary Completion: 2020-07-02
• Study First Posted: 2020-07-07
• Last Update Posted: 2020-07-07
• Study Completion: 2020-07-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients older than 21, who will get catarct surgeyr
• Patients whose visual acuity anticipated better than 20/25 after surgery
• Patients with informed consent
• Patients with meibomian gland dysfunction

Exclusion Criteria

• ocular injury, active injection
• uncontrolled systemic disease
• Contact lens wear within 1 month
• Allergic to fluorescein sodium or topical anesthetics
• ocular surgery or trauma within 6 months
• disorder of lid anatomy
• other reason for decreased vision other than cataract
• anticipated visual acuity less than 20/25
• Patients less than 20 years.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
improvement of dry eye symptom	1 month	ocular dryness

Trial Locations

Locations (1)

Samsung Medical Center; 🇰🇷 Seoul, Korea, Republic of